XML 32 R16.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cash Overdrafts, Cash Equivalents, and Supplemental Cash Flow Disclosure
 12 Months Ended
Dec. 31, 2023
Cash Overdrafts, Cash Equivalents, and Supplemental Cash Flow Disclosure [Abstract]  
Cash Overdrafts, Cash Equivalents, and Supplemental Cash Flow Disclosure 9.    Cash Overdrafts, Cash Equivalents, and Supplemental Cash Flow Disclosure

Included in the accompanying Consolidated Balance Sheets are $690,000, $1.9 million, and $1.9 million of capitalized property and equipment which were not paid for as of December 31, 2023, 2022, and 2021, respectively. These amounts have been excluded from capital expenditures in the accompanying Consolidated Statements of Cash Flows. There are no material non-cash amounts included in interest expense for any period presented.

There is $15.7 million of cash overdrafts included in accounts payable as of December 31, 2023. There were no cash overdrafts included in accounts payable as of December 31, 2022

From time to time throughout the year, we invest excess cash in money market funds directly with major commercial banks. We closely monitor the creditworthiness of the institutions with which we invest our overnight funds. In 2023, Chemed began investing excess cash in a money market fund holding US Treasuries. Deposits and withdrawals are made daily, based on the Company’s excess cash balance. There are no penalties associated with withdrawals. The accounts bear interest at a normal market rate.